{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:40:26Z","timestamp":1793605226707,"version":"4.5.0"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Status epilepticus (SE) is a medical emergency resulting from the failure of the mechanisms involved in seizure termination or from the initiation of pathways involved in abnormally prolonged seizures, potentially leading to long-term consequences, including neuronal death and impaired neuronal networks. It can eventually evolve to refractory status epilepticus (RSE), in which the administration of a benzodiazepine and another anti-seizure medications (ASMs) had been ineffective, and super-refractory status epilepticus (SRSE), which persists for more than 24\u2005h after the administration of general anesthesia. Objective of the present review is to highlight the link between inflammation and SE. Several preclinical and clinical studies have shown that neuroinflammation can contribute to seizure onset and recurrence by increasing neuronal excitability. Notably, microglia and astrocytes can promote neuroinflammation and seizure susceptibility. In fact, inflammatory mediators released by glial cells might enhance neuronal excitation and cause drug resistance and seizure recurrence. Understanding the molecular mechanisms of neuroinflammation could be crucial for improving SE treatment, wich is currently mainly addressed with benzodiazepines and eventually phenytoin, valproic acid, or levetiracetam. IL-1\u03b2 signal blockade with Anakinra has shown promising results in avoiding seizure recurrence and generalization in inflammatory refractory epilepsy. Inhibiting the IL-1\u03b2 converting enzyme (ICE)\/caspase-1 is also being investigated as a possible target for managing drug-resistant epilepsies. Targeting the ATP-P2X7R signal, which activates the NLRP3 inflammasome and triggers inflammatory molecule release, is another avenue of research. Interestingly, astaxanthin has shown promise in attenuating neuroinflammation in SE by inhibiting the ATP-P2X7R signal. Furthermore, IL-6 blockade using tocilizumab has been effective in RSE and in reducing seizures in patients with febrile infection-related epilepsy syndrome (FIRES). Other potential approaches include the ketogenic diet, which may modulate pro-inflammatory cytokine production, and the use of cannabidiol (CBD), which has demonstrated antiepileptic, neuroprotective, and anti-inflammatory properties, and targeting HMGB1-TLR4 axis. Clinical experience with anti-cytokine agents such as Anakinra and Tocilizumab in SE is currently limited, although promising. Nonetheless, Etanercept and Rituximab have shown efficacy only in specific etiologies of SE, such as autoimmune encephalitis. Overall, targeting inflammatory pathways and cytokines shows potential as an innovative therapeutic option for drug-resistant epilepsies and SE, providing the chance of directly addressing its underlying mechanisms, rather than solely focusing on symptom control.<\/jats:p>","DOI":"10.3389\/fped.2023.1251914","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T15:58:09Z","timestamp":1700755089000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":80,"title":["Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay"],"prefix":"10.3389","volume":"11","author":[{"given":"T.","family":"Foiadelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Scacciati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Volpedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Smaldone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bonuccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Savasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Striano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013report of the ILAE task force on classification of Status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12974-018-1192-7","article-title":"The role of inflammation in the development of epilepsy","volume":"15","author":"Rana","year":"2018","journal-title":"J Neuroinflammation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1759720X20959575","DOI":"10.1177\/1759720X20959575","article-title":"The off-label use of anakinra in pediatric systemic autoinflammatory diseases","volume":"12","author":"Maniscalco","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"106588","DOI":"10.1016\/j.eplepsyres.2021.106588","article-title":"The role of inflammatory mediators in epilepsy: focus on developmental and epileptic encephalopathies and therapeutic implications","volume":"172","author":"Orsini","year":"2021","journal-title":"Epilepsy Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","article-title":"Infections, inflammation and epilepsy","volume":"131","author":"Vezzani","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1523\/JNEUROSCI.0037-06.2006","article-title":"The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus","volume":"26","author":"Wallraff","year":"2006","journal-title":"J Neurosci"},{"key":"B7","first-page":"174","article-title":"P2x7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control","volume":"4","author":"Engel","year":"2012","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/neu.2016.47","article-title":"Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms","volume":"29","author":"Alyu","year":"2016","journal-title":"Acta Neuropsychiatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","article-title":"Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases","volume":"23","author":"Viviani","year":"2003","journal-title":"J Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"637703","DOI":"10.3389\/fnagi.2021.637703","article-title":"Interleukin-1\u03b2 modulates synaptic transmission and synaptic plasticity during the acute phase of sepsis in the senescence-accelerated mouse hippocampus","volume":"13","author":"Hoshino","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1471-4159.2009.06099.x","article-title":"Tumor necrosis factor receptor-associated protein 1 regulates cell adhesion and synaptic morphology via modulation of N-cadherin expression","volume":"110","author":"Kubota","year":"2009","journal-title":"J Neurochem"},{"key":"B12","doi-asserted-by":"publisher","first-page":"21362","DOI":"10.1074\/jbc.M600504200","article-title":"Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner","volume":"281","author":"Takeuchi","year":"2006","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.yfrne.2011.12.002","article-title":"Cytokines and brain excitability","volume":"33","author":"Galic","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1523\/JNEUROSCI.4486-04.2005","article-title":"Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha","volume":"25","author":"Stellwagen","year":"2005","journal-title":"J Neurosci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a major cytokine in the central nervous system","volume":"8","author":"Erta","year":"2012","journal-title":"Int J Biol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1111\/j.1528-1167.2012.03637.x","article-title":"Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches","volume":"53","author":"Marchi","year":"2012","journal-title":"Epilepsia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1046\/j.1532-5415.2002.50619.x","article-title":"Cytokines and cognition-the case for a head-to-toe inflammatory paradigm","volume":"50","author":"Wilson","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1523\/JNEUROSCI.6210-10.2011","article-title":"Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy","volume":"31","author":"Zattoni","year":"2011","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/nm.1878","article-title":"A role for leukocyte-endothelial adhesion mechanisms in epilepsy","volume":"14","author":"Fabene","year":"2008","journal-title":"Nat Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.nbd.2017.10.012","article-title":"Status epilepticus triggers long-lasting activation of complement C1q-C3 signaling in the hippocampus that correlates with seizure frequency in experimental epilepsy","volume":"109","author":"Schartz","year":"2018","journal-title":"Neurobiol Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fncel.2017.00428","article-title":"The calcineurin inhibitor FK506 prevents cognitive impairment by inhibiting reactive astrogliosis in pilocarpine-induced status epilepticus rats","volume":"11","author":"Liu","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/epi.12461","article-title":"Cyclooxygenase-2 in epilepsy","volume":"55","author":"Rojas","year":"2014","journal-title":"Epilepsia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.tips.2016.03.001","article-title":"Anti-inflammatory small molecules to treat seizures and epilepsy: from bench to bedside","volume":"37","author":"Dey","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/ana.26173","article-title":"Subicular caspase-1 contributes to pharmacoresistance in temporal lobe epilepsy","volume":"90","author":"Xu","year":"2021","journal-title":"Ann Neurol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"106027","DOI":"10.1016\/j.nbd.2023.106027","article-title":"Neuroinflammation microenvironment sharpens seizure circuit","volume":"178","author":"Villasana-Salazar","year":"2023","journal-title":"Neurobiol Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-8-14","article-title":"Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1\u03b2 and NMDA stimulation","volume":"8","author":"Gardoni","year":"2011","journal-title":"J Neuroinflammation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.yebeh.2011.07.024","article-title":"The NMDA receptor complex as a therapeutic target in epilepsy: a review","volume":"22","author":"Ghasemi","year":"2011","journal-title":"Epilepsy Behav"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1442","DOI":"10.1038\/cddis.2014.390","article-title":"Seizure activity results in calcium- and mitochondria-independent ROS production via NADPH and xanthine oxidase activation","volume":"5","author":"Kovac","year":"2014","journal-title":"Cell Death Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1093\/brain\/awn271","article-title":"A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta","volume":"131","author":"Balosso","year":"2008","journal-title":"Brain"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1089\/ars.2013.5349","article-title":"Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating toll-like receptor 4-dependent signaling in hippocampal neurons","volume":"21","author":"Balosso","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"B34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.nbd.2013.03.006","article-title":"Receptor for advanced glycation endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures","volume":"58","author":"Iori","year":"2013","journal-title":"Neurobiol Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/nan.12444","article-title":"Review: neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies","volume":"44","author":"van Vliet","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.expneurol.2013.05.010","article-title":"The dual role of TNF-\u03b1 and its receptors in seizures","volume":"247","author":"Balosso","year":"2013","journal-title":"Exp Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5150678","DOI":"10.1155\/2017\/5150678","article-title":"The role of microglia and macrophages in CNS homeostasis, autoimmunity, and cancer","volume":"2017","author":"Yin","year":"2017","journal-title":"J Immunol Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"10528","DOI":"10.1523\/JNEUROSCI.0416-14.2014","article-title":"Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus","volume":"34","author":"Eyo","year":"2014","journal-title":"J Neurosci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12974-017-0797-6","article-title":"Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures","volume":"14","author":"Yang","year":"2017","journal-title":"J Neuroinflammation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.nbd.2008.07.003","article-title":"Decreased glutamate transport enhances excitability in a rat model of cortical dysplasia","volume":"32","author":"Campbell","year":"2008","journal-title":"Neurobiol Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1083\/jcb.201611078","article-title":"Astrocytic TLR4 at the crossroads of inflammation and seizure susceptibility","volume":"215","author":"Henneberger","year":"2016","journal-title":"J Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s11033-021-06896-8","article-title":"Pharmacological modulation of cytokines correlating neuroinflammatory cascades in epileptogenesis","volume":"49","author":"Vishwakarma","year":"2022","journal-title":"Mol Biol Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.plefa.2011.04.003","article-title":"Modulation of leukotriene D4 attenuates the development of seizures in mice","volume":"85","author":"Rehni","year":"2011","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B44","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s13311-011-0039-z","article-title":"Interleukin-1\u03b2 biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice","volume":"8","author":"Maroso","year":"","journal-title":"Neurotherapeutics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.eplepsyres.2010.06.012","article-title":"Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice","volume":"91","author":"Fischborn","year":"2010","journal-title":"Epilepsy Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/epi.13783","article-title":"Neuroinflammatory targets and treatments for epilepsy validated in experimental models","volume":"58","author":"Aronica","year":"2017","journal-title":"Epilepsia"},{"key":"B47","doi-asserted-by":"publisher","first-page":"18291","DOI":"10.1038\/s41598-020-75500-z","article-title":"Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases","volume":"10","author":"Molero-Luis","year":"2020","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"104589","DOI":"10.1016\/j.ebiom.2023.10458","article-title":"CSF Neopterin, quinolinic acid and kynurenine\/tryptophan ratio are biomarkers of active neuroinflammation","volume":"91","author":"Yan","year":"2023","journal-title":"EBioMedicine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2015.10.003","article-title":"Neopterin as a potential cytoprotective brain molecule","volume":"71","author":"Ghisoni","year":"2015","journal-title":"J Psychiatr Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"104024","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: an endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitr\u00f3n","year":"2013","journal-title":"Oxid Med Cell Longevity"},{"key":"B51","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12974-020-01844-y","article-title":"Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression","volume":"17","author":"Sundaram","year":"2020","journal-title":"J Neuroinflammation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1178646919868978","DOI":"10.1177\/1178646919868978","article-title":"The plasma [kynurenine]\/[tryptophan] ratio and indoleamine 2,3-dioxygenase: time for appraisal","volume":"12","author":"Badawy","year":"2019","journal-title":"Int J Tryptophan Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"103833","DOI":"10.1016\/j.ebiom.2022.103833","article-title":"Seizure modulation by the gut microbiota and tryptophan-kynurenine metabolism in an animal model of infantile spasms","volume":"76","author":"Mu","year":"2022","journal-title":"EBioMedicine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.3390\/cells11223560","article-title":"Differential levels of tryptophan-kynurenine pathway metabolites in the hippocampus, anterior temporal lobe, and neocortex in an animal model of temporal lobe epilepsy","volume":"11","author":"Dey","year":"2022","journal-title":"Cells"},{"key":"B55","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ana.26627","article-title":"Cytokines in new-onset refractory Status epilepticus predict outcomes","volume":"94","author":"Hanin","year":"2023","journal-title":"Ann Neurol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00381-017-3359-4","article-title":"Cerebrospinal fluid neuron specific enolase, interleukin-1\u03b2 and erythropoietin concentrations in children after seizures","volume":"33","author":"Shi","year":"2017","journal-title":"Childs Nerv Syst"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1111\/epi.16275","article-title":"Etiology is the key determinant of neuroinflammation in epilepsy: elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus","volume":"60","author":"Kothur","year":"2019","journal-title":"Epilepsia"},{"key":"B58","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"B59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s13312-020-1759-0","article-title":"Refractory and super-refractory Status epilepticus","volume":"57","author":"Samanta","year":"2020","journal-title":"Indian Pediatr"},{"key":"B60","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.yebeh.2015.02.030","article-title":"Nonintravenous midazolam versus in- travenous or rectal diazepam for the treatment of early status epilepticus: a sys- tematic review with meta-analysis","volume":"49","author":"Brigo","year":"2015","journal-title":"Epilepsy Behav"},{"key":"B62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/(SICI)1098-1136(199601)16:1%3C65::AID-GLIA7%3E3.0.CO;2-A","article-title":"Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line","volume":"16","author":"Park","year":"1996","journal-title":"Glia"},{"key":"B63","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.nbd.2003.07.002","article-title":"Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro","volume":"14","author":"Wilms","year":"2003","journal-title":"Neurobiol. Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/135502801753170345","article-title":"Diazepam inhibits HIV-1 tat-induced migration of human microglia","volume":"7","author":"Lokensgard","year":"2001","journal-title":"J. Neurovirol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/1535759720928269","article-title":"Treatment of refractory convulsive status epilepticus: a comprehensive review by the American epilepsy society treatments committee","volume":"20","author":"Vossler","year":"2020","journal-title":"Epilepsy Curr"},{"key":"B66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/1535759720928269","article-title":"Treatment of refractory convulsive Status epilepticus: a comprehensive review by the American epilepsy society treatments committee","volume":"20","author":"Amengual-Gual","year":"2020","journal-title":"Epilepsy Curr"},{"key":"B67","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.seizure.2019.10.006","article-title":"Medical management of status epilepticus: emergency room to intensive care unit","volume":"75","author":"Crawshaw","year":"2020","journal-title":"Seizure"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3390\/ph14111132","article-title":"Thymoquinone potentiates the effect of phenytoin against electroshock-induced convulsions in rats by reducing the hyperactivation of m-TOR pathway and neuroinflammation: evidence from in vivo","volume":"14","author":"Pottoo","year":"2021","journal-title":"In Vitro and Computational Studies. Pharmaceuticals (Basel)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejphar.2013.03.020","article-title":"Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation","volume":"707","author":"Suda","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jamcollsurg.2018.12.026","article-title":"Valproic acid and neural apoptosis, inflammation, and degeneration 30 days after traumatic brain injury, hemorrhagic shock, and polytrauma in a swine model","volume":"228","author":"Chang","year":"2019","journal-title":"J Am Coll Surg"},{"key":"B71","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/s0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.molbrainres.2004.10.021","article-title":"Valproate pretreatment protects dopaminergic neurons from LPS- induced neurotoxicity in rat primary midbrain cultures: role of microglia","volume":"134","author":"Peng","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/ph15040475","article-title":"Levetiracetam mechanisms of action: from molecules to systems","volume":"15","author":"Contreras-Garc\u00eda","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2016.09.038","article-title":"Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice","volume":"1652","author":"Itoh","year":"2016","journal-title":"Brain Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"134363","DOI":"10.1016\/j.neulet.2019.134363","article-title":"Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: a comparative study of levetiracetam, valproate and carbamazepine","volume":"708","author":"Itoh","year":"2019","journal-title":"Neurosci Lett"},{"key":"B76","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.pediatrneurol.2008.01.001","article-title":"Treatment of refractory status epilepticus: literature review and a proposed protocol","volume":"38","author":"Abend","year":"2008","journal-title":"Pediatr Neurol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s12640-022-00508-4","article-title":"Midazolam ameliorates impairment of the blood-brain barrier (BBB) against LPS","volume":"40","author":"Zheng","year":"2022","journal-title":"Neurotox Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1742-2094-8-68","article-title":"Midazolam suppresses interleukin-1\u03b2-induced interleukin-6 release from rat glial cells","volume":"8","author":"Tanabe","year":"2011","journal-title":"J Neuroinflamm"},{"key":"B79","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/nn1472","article-title":"ATP mediates rapid microglial response to local brain injury in vivo","volume":"8","author":"Davalos","year":"2005","journal-title":"Nat. Neurosci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jconrel.2017.03.032","article-title":"Effect of anesthetics on microglial activation and nanoparticle uptake: implications for drug delivery in traumatic brain injury","volume":"263","author":"Kannan","year":"2017","journal-title":"J Control Release"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e52887","DOI":"10.1371\/journal.pone.0052887","article-title":"Differential general anesthetic effects on microglial cytokine expression","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS One"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e0178098","DOI":"10.1371\/journal.pone.0178098","article-title":"Intracellular Ca2\u2009+\u2009homeostasis and JAK1\/STAT3 pathway are involved in the protective effect of propofol on BV2 microglia against hypoxia-induced inflammation and apoptosis","volume":"12","author":"Lu","year":"2017","journal-title":"PLoS One"},{"key":"B83","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2165\/00002018-200831040-00003","article-title":"Propofol infusion syndrome: an overview of a perplexing disease","volume":"31","author":"Fodale","year":"2008","journal-title":"Drug Saf"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1586\/14737175.2015.1079130","article-title":"Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application","volume":"15","author":"Vezzani","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"B85","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.seizure.2018.05.012","article-title":"Pediatric refractory and super-refractory status epilepticus","volume":"68","author":"Vasquez","year":"2019","journal-title":"Seizure"},{"key":"B86","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12917-016-0721-9","article-title":"Comparison of the effects of ketamine and fentanyl-midazolam-medetomidine for sedation of rhesus macaques (Macaca mulatta)","volume":"12","author":"Bertrand","year":"2016","journal-title":"BMC Vet. Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1177\/0883073817698629","article-title":"Increasing ketamine use for refractory status epilepticus in US pediatric hospitals","volume":"32","author":"Keros","year":"2017","journal-title":"J Child Neurol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e12741","DOI":"10.14814\/phy2.12741","article-title":"Ketamine decreases inflammatory and immune pathways after transient hypoxia in late gestation fetal cerebral cortex","volume":"4","author":"Chang","year":"2016","journal-title":"Physiol. Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/phar.2065","article-title":"Ketamine infusion for adjunct sedation in mechanically ventilated adults","volume":"38","author":"Groetzinger","year":"2018","journal-title":"Pharmacotherapy"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1528-1167.2011.03028.x","article-title":"The pivotal role of immunity and inflammatory processes in epilepsy is increasingly recognized: introduction","volume":"52","author":"Vezzani","year":"2011","journal-title":"Epilepsia"},{"key":"B92","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1528-1167.2009.02370.x","article-title":"Basic mechanisms of status epilepticus due to infection and inflammation","volume":"50","author":"Vezzani","year":"2009","journal-title":"Epilepsia"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/epi.12331","article-title":"Hypothermia for pediatric refractory status epilepticus","volume":"54","author":"Guilliams","year":"2013","journal-title":"Epilepsia"},{"key":"B94","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.pediatrneurol.2012.08.013","article-title":"Therapeutic hypothermia for febrile infection-related epilepsy syndrome in two patients","volume":"47","author":"Lin","year":"2012","journal-title":"Pediatr Neurol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1089\/ther.2012.0013","article-title":"Therapeutic hypothermia for refractory status epilepticus in a child with malignant migrating partial seizures of infancy and SCN1A mutation: a case report","volume":"2","author":"Shein","year":"2012","journal-title":"Ther Hypothermia Temp Manage"},{"key":"B96","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12028-008-9092-9","article-title":"Hypothermia for refractory status epilepticus","volume":"9","author":"Corry","year":"2008","journal-title":"Neurocrit Care"},{"key":"B97","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/epi.12144","article-title":"Therapeutic brain hypothermia, its mechanisms of action, and its prospects as a treatment for epilepsy","volume":"54","author":"Motamedi","year":"2013","journal-title":"Epilepsia"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1080\/21645515.2015.1034921","article-title":"Epilepsy and innate immune system: a possible immunogenic predisposition and related therapeutic implications","volume":"11","author":"Matin","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.bbi.2011.03.018","article-title":"IL-1 receptor\/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures","volume":"25","author":"Vezzani","year":"2011","journal-title":"Brain Behav Immun"},{"key":"B100","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/epi.12461","article-title":"Cyclooxygenase-2 in epilepsy","volume":"55","author":"Rojas","year":"2014","journal-title":"Epilepsia"},{"key":"B101","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1523\/JNEUROSCI.23-03-00955.2003","article-title":"Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration","volume":"23","author":"Xiong","year":"2003","journal-title":"J Neurosci"},{"key":"B102","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1201\/9781420085594-c4","article-title":"Brain inflammation and epilepsy","volume-title":"Epilepsy: Mechanisms, models and translational perspectives","author":"Ravizza","year":"2010"},{"key":"B103","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1358\/dot.2009.45.2.1322481","article-title":"Cyclooxygenase in epilepsy: from perception to application","volume":"45","author":"Kulkarni","year":"2009","journal-title":"Drugs Today (Barc)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1111\/epi.17397","article-title":"International consensus recommendations for management of new onset refractory Status epilepticus (NORSE) incl. Febrile infection-related epilepsy syndrome (FIRES): statements and supporting evidence","volume":"63","author":"Wickstrom","year":"2022","journal-title":"Epilepsia"},{"key":"B105","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1535-7511.2007.00165.x","article-title":"New roles for interleukin-1 Beta in the mechanisms of epilepsy","volume":"7","author":"Vezzani","year":"2007","journal-title":"Epilepsy Curr"},{"key":"B106","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/epi4.12317","article-title":"Therapeutic effect of anakinra in the relapsing chronic phase of febrile infection-related epilepsy syndrome","volume":"4","author":"Dilena","year":"2019","journal-title":"Epilepsia Open"},{"key":"B107","doi-asserted-by":"publisher","first-page":"939e45","DOI":"10.1002\/ana.24806","article-title":"Febrile infection-related epilepsy syndrome treated with anakinra","volume":"80","author":"Kenney-Jung","year":"2016","journal-title":"Ann Neurol"},{"key":"B108","first-page":"135","article-title":"Febrile infection-related epilepsy syndrome treated successfully with anakinra in a 21- year- old woman","volume":"118","author":"Westbrook","year":"2019","journal-title":"WMJ"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1517\/13543784.10.7.1207","article-title":"ICE\/Caspase-1 inhibitors as novel anti- inflammatory drugs","volume":"10","author":"Randle","year":"2001","journal-title":"Expert Opin Invest Drugs"},{"key":"B110","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1124\/jpet.106.111344","article-title":"(S)-1-((S)-2-{[1-(4-amino-3-chloro- phenyl)-methanoyl]-amino}-3, 3-dimethyl-butanoyl)- pyrrolidine-2-carboxylic acid ((2R, 3S)-2-ethoxy-5- oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme\/ caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1b and IL-18","volume":"321","author":"Wannamaker","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/j.1528-1167.2006.00590.x","article-title":"Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy","volume":"47","author":"Ravizza","year":"2006","journal-title":"Epilepsia"},{"key":"B112","year":""},{"key":"B113","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nm.2127","article-title":"Toll-like receptor 4 and high- mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures","volume":"16","author":"Maroso","year":"2010","journal-title":"Nat Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/brain\/awr032","article-title":"Activation of toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical devel- opment","volume":"134","author":"Zurolo","year":"2011","journal-title":"Brain"},{"key":"B115","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/biof.118","article-title":"Neuroprotective properties of resveratrol in different neurodegenerative disorders","volume":"36","author":"Albani","year":"2010","journal-title":"Biofactors"},{"key":"B116","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.4049\/jimmunol.175.5.3339","article-title":"Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex","volume":"175","author":"Youn","year":"2005","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2010.03.043","article-title":"Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in micro- glial activation","volume":"636","author":"Zhang","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"21875","DOI":"10.1074\/jbc.273.34.21875","article-title":"Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells","volume":"273","author":"Subbaramaiah","year":"1998","journal-title":"J Biol Chem"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1089\/152308601317203567","article-title":"Biological effects of resveratrol","volume":"3","author":"Bhat","year":"2001","journal-title":"Antioxid Redox Signal"},{"key":"B120","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5698\/1535-7597.18.1.42","article-title":"Persistent protection against pathology and paroxysms by P2X7R antagonism","volume":"18","author":"Christian","year":"2018","journal-title":"Epilepsy Currents"},{"key":"B121","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12974-018-1353-8","article-title":"A central role for P2X7 receptors in human microglia","volume":"15","author":"Janks","year":"2018","journal-title":"J Neuroinflamm"},{"key":"B122","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fnins.2017.00021","article-title":"The ATP-gated P2X7 receptor as a target for the treatment of drug-resistant epilepsy","volume":"11","author":"Beamer","year":"2017","journal-title":"Front Neurosci"},{"key":"B123","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"B124","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cyto.2019.03.019","article-title":"Extracellular ATP activates P2X7R-NF -\u03baB (p65) pathway to promote the maturation of bone marrow- derived dendritic cells of mice","volume":"119","author":"Yu","year":"2019","journal-title":"Cytokine"},{"key":"B125","doi-asserted-by":"publisher","first-page":"106275","DOI":"10.1016\/j.yebeh.2019.04.028","article-title":"Inflammation and reactive oxygen species in status epilepticus: bio- markers and implications for therapy","volume":"101","author":"Terrone","year":"2019","journal-title":"Epilepsy Behav"},{"key":"B126","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/21691401.2019.1580286","article-title":"Astaxanthin induces apopto- sis and increases activity of antioxidant enzymes in LS-180 cells","volume":"47","author":"Hormozi","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.brainresbull.2019.03.009","article-title":"Neuroprotective effect of astaxanthin on newborn rats exposed to prenatal maternal seizures","volume":"148","author":"Lu","year":"2019","journal-title":"Brain Res Bull"},{"key":"B128","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fncel.2019.00123","article-title":"The neuroprotective effect of astaxanthin on pilocarpine-induced status epilepticus in rats","volume":"13","author":"Deng","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2147\/DDDT.S249162","article-title":"Astaxanthin attenuates neuroinflammation in Status epilepticus rats by regulating the ATP-P2X7R signal","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"B130","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.seizure.2010.12.005","article-title":"Cytokines and epilepsy","volume":"20","author":"Li","year":"2011","journal-title":"Seizure"},{"key":"B131","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/bs8020021","article-title":"Follow-up of peripheral IL-1\u03b2 and IL-6 and relation with apoptotic death in drug-resistant temporal lobe epilepsy patients submitted to surgery","volume":"8","author":"Lorigados Pedre","year":"2018","journal-title":"Behav Sci"},{"key":"B132","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.25374","article-title":"Tocilizumab treatment for new onset refractory status epilepticus","volume":"84","author":"Jun","year":"2018","journal-title":"Ann Neurol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"577142","DOI":"10.1016\/j.jneuroim.2019.577142","article-title":"Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: experience in two patients","volume":"340","author":"Cantar\u00edn-Extremera","year":"2020","journal-title":"J Neuroimmunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2329048X20979253","DOI":"10.1177\/2329048X20979253","article-title":"Interleukin-6 blockade with tocilizumab in anakinra-refractory febrile infection-related epilepsy syndrome (FIRES)","volume":"7","author":"Stredny","year":"2020","journal-title":"Child Neurol Open"},{"key":"B135","doi-asserted-by":"publisher","first-page":"106454","DOI":"10.1016\/j.eplepsyres.2020.106454","article-title":"Ketogenic diet and neuroinflammation","volume":"167","author":"Koh","year":"2020","journal-title":"Epilepsy Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"B137","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1038\/ncomms4944","article-title":"The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages","volume":"5","author":"Rahman","year":"2014","journal-title":"Nat Commun"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e1412","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut Microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"B139","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ana.24424","article-title":"Ketone bodies mediate antiseizure effects through mitochondrial permeability transition","volume":"78","author":"Kim","year":"2015","journal-title":"Ann Neurol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"B141","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.3390\/nu15173680","article-title":"The influence of ketogenic diet on gut Microbiota: potential benefits, risks and indications","volume":"15","author":"Santangelo","year":"2023","journal-title":"Nutrients"},{"key":"B142","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/0883073816669450","article-title":"Cannabidiol as a potential treatment for febrile infection-related epilepsy syndrome (FIRES) in the acute and chronic phases","volume":"32","author":"Gofshteyn","year":"2017","journal-title":"J. Child Neurol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.3390\/molecules27154961","article-title":"Neuroprotection of cannabidiol, its synthetic derivatives and combination preparations against microglia-mediated neuroinflammation in neurological disorders","volume":"27","author":"Yousaf","year":"2022","journal-title":"Molecules"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1021\/jm050709m","article-title":"New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity","volume":"49","author":"Ben-Shabat","year":"2006","journal-title":"J Med Chem"},{"key":"B145","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.3390\/molecules27154961","article-title":"Neuroprotection of cannabidiol, its synthetic derivatives and combination preparations against microglia-mediated neuroinflammation in neurological disorders","volume":"27","author":"Yousaf","year":"2022","journal-title":"Molecules"},{"key":"B146","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ebcr.2018.07.004","article-title":"Successful use of pure cannabidiol for the treatment of super-refractory status epilepticus","volume":"10","author":"Rajaraman","year":"2018","journal-title":"Epilepsy Behav Case Rep"},{"key":"B147","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14581\/jer.20008","article-title":"Diagnosis and treatment of Status epilepticus","volume":"10","author":"Lee","year":"2020","journal-title":"J Epilepsy Res"},{"key":"B148","doi-asserted-by":"publisher","first-page":"741244","DOI":"10.3389\/fneur.2022.741244","article-title":"Targeting inflammatory mediators in epilepsy: a systematic review of its molecular basis and clinical applications","volume":"13","author":"Costagliola","year":"2022","journal-title":"Front Neurol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.3390\/ijms22126282","article-title":"Towards a treatment for neuroinflammation in epilepsy: interleukin-1 receptor antagonist, anakinra, as a potential treatment in intractable epilepsy","volume":"22","author":"Yamanaka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","article-title":"Tocilizumab (Actemra)","volume":"13","author":"Sheppard","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"B151","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/acn3.51229","article-title":"Anakinra usage in febrile infection related epilepsy syndrome: an international cohort","volume":"7","author":"Lai","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ejpn.2019.08.001","article-title":"Centromedian thalamic nuclei deep brain stimulation and anakinra treatment for FIRES\u2014two different outcomes","volume":"23","author":"Sa","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.seizure.2022.06.012","article-title":"Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): effectiveness and safety from a case-series","volume":"100","author":"Aledo-Serrano","year":"2022","journal-title":"Seizure"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1100551","DOI":"10.3389\/fneur.2023.1100551","article-title":"Long-term neuropsychological outcomes in children with febrile infection-related epilepsy syndrome (FIRES) treated with anakinra","volume":"14","author":"Shrestha","year":"2023","journal-title":"Front Neurol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1111\/epi.17591","article-title":"Treatment of new onset refractory status epilepticus\/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult","volume":"64","author":"Girardin","year":"2023","journal-title":"Epilepsia"},{"key":"B156","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1111\/ene.15440","article-title":"Treatment of COVID-19-induced refractory status epilepticus by tocilizumab","volume":"29","author":"Kizilkilic","year":"2022","journal-title":"Eur J Neurol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/19418744211000980","article-title":"Recurrent Status epilepticus in the setting of chimeric antigen receptor (CAR)-T cell therapy","volume":"12","author":"Reveron-Thornton","year":"2022","journal-title":"Neurohospitalist"},{"key":"B158","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/epi.13387","article-title":"Anti-tumor necrosis factor alpha therapy (Adalimumab) in rasmussen\u2019s encephalitis: an open pilot study","volume":"57","author":"Lagarde","year":"2016","journal-title":"Epilepsia"},{"key":"B159","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.seizure.2020.07.023","article-title":"Rasmussen\u2019s encephalitis: from immune pathogenesis towards targeted-therapy","volume":"81","author":"Orsini","year":"2020","journal-title":"Seizure"},{"key":"B160","doi-asserted-by":"publisher","first-page":"e0146455","DOI":"10.1371\/journal.pone","article-title":"Effect of immunotherapy on seizure outcome in patients with autoimmune encephalitis: a prospective observational registry study","volume":"11","author":"Byun","year":"2016","journal-title":"PLoS One"},{"key":"B161","doi-asserted-by":"publisher","first-page":"e1757\u201367","DOI":"10.1212\/WNL.0000000000012766","article-title":"Safety and efficacy of natalizumab as adjunctive therapy for people with drug-resistant epilepsy: a phase 2 study","volume":"97","author":"French","year":"2021","journal-title":"Neur"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1251914\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T15:58:15Z","timestamp":1700755095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1251914\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,21]]},"references-count":161,"alternative-id":["10.3389\/fped.2023.1251914"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1251914","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,21]]},"article-number":"1251914"}}